Clinical studies have demonstrated a significant positive correlation between serum copper levels and HIF-1α levels in patients with liver cancer, suggesting that copper accumulation may lead to the activation of HIF-1α and promote the development of liver cancer (103). This evidence concerns the gene HIF1A and liver cancer.